HCC RISK SCORES: APPLICATION OF THE CU-HCC, GAG-HCC AND PAGE-B SCORES TO CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) Kim, W. R., Loomba, R., Berg, T., Schall, R., Yee, L., Dinh, P., Flaherty, J. F., Martins, E. B., Jacobson, I., Fung, S., Gurel, S., Buti, M., Marcellin, P. ELSEVIER SCIENCE BV. 2015: S561

View details for DOI 10.1016/S0168-8278(15)30849-7

View details for Web of Science ID 000362830600361